IP Library › Granted Patent US 10,597,706
Granted Patent B2
US 10,597,706 · App. 15/354,491 · Granted Mar 24, 2020

Methods and kits for reducing adapter-dimer formation

Inventors: Masoud Toloue (Austin, TX); Adam R. Morris (Austin, TX); Kevin D. Allen (Austin, TX)
Assignee: BIOO Scientific Corporation
C12Q1/6855C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,597,706
App. No.
15/354,491
Granted
Mar 24, 2020
Kind
B2
Abstract

The current teachings relate to methods for reducing adapter-dimer formation, particularly when preparing nucleic acids of interest for subsequent amplification and/or sequencing. Also described are kits for use in performing certain disclosed methods.

Claims (27)

1. A method for reducing adapter-dimer formation comprising:

combining a sample comprising target small ribonucleic acids (RNA), at least one deoxyribonucleic acid (DNA) 3′ adapter, and at least one first RNA ligase to form a first reaction composition;

incubating the first reaction composition under conditions suitable for first ligation products to be generated, to form a second reaction composition comprising first ligation products and at least some un-ligated 3′ adapters;

combining at least one oligonucleotide comprising a reverse transcription priming site with the second reaction composition to form a third reaction composition;

incubating the third reaction composition under conditions suitable for at least some of the oligonucleotides to anneal with at least some of the first reaction products and at least some of the un-ligated 3′ adapters to form 3′ adapter-oligonucleotide duplexes comprising a single-stranded 5′ overhang portion;

combining at least one DNA-dependent DNA polymerase to the third reaction composition and incubating under conditions suitable for the polymerase to convert at least some of the 3′ adapter-oligonucleotide duplexes comprising single-stranded 5′ overhang portions to double-stranded blunt ended adapter-oligonucleotide duplexes by end-filling;

combining at least one second ligase and at least one 5′ adapter to the third reaction composition comprising double-stranded adapter-oligonucleotide duplexes and first ligation products and incubating under conditions suitable for forming at least some second ligation products;

combining at least one reverse transcriptase with the second ligation products to generate double-stranded second ligation products, thereby reducing adapter-dimer formation.

2. The method of claim 1 , wherein the first ligase comprises T4 RNA ligase 2 or truncated T4 RNA ligase 2; the DNA-dependent DNA polymerase comprises T4 DNA polymerase; and the second ligase comprises T4 RNA ligase 1 or Methanobacterium thermoautotrophicum RNA ligase.

3. The method of claim 1 , wherein the oligonucleotide is annealed to the 3′ adapter prior to, during, or after ligating the 3′ adapter to a target ribonucleic acid.

4. The method of claim 1 wherein the 3′ adapter comprises 1-25 randomized bases at the 5′ end.

5. The method of claim 1 wherein the 5′ adapter comprises 1-25 randomized bases at the 3′ end.

6. The method of claim 1 , further comprising amplifying at least some of the double-stranded second ligation products to generate amplification products.

7. The method of claim 6 , wherein the amplifying comprises Polymerase Chain Reaction (PCR).

8. The method of claim 6 , further comprising separating at least some of the amplification products by size.

9. A method for reducing, adapter-dimer formation comprising:

combining a sample comprising target small ribonucleic acids, at least one 3′ adapter annealed to an oligonucleotide comprising a reverse transcription primer binding site, and at least one first ligase to form a first reaction composition, wherein the 3′ adapter annealed with the oligonucleotide comprises a single-stranded 5′ overhang portion;

incubating the first reaction composition under conditions suitable for first ligation products to be generated, to form a second reaction composition comprising first ligation products and at least some un-ligated 3′ adapters annealed to oligonucleotides;

combining at least one DNA-dependent DNA polymerase with the second reaction composition and incubating under conditions suitable for the polymerase to convert at least some of the single-stranded 5′ overhang portions of the 3′ adapters annealed to the oligonucleotides to double-stranded blunt ended adapter-oligonucleotide duplexes lacking overhang portions by end-filling;

combining at least one second ligase and at least one 5′ adapter to the second reaction composition comprising double-stranded adapter-oligonucleotide duplexes and first ligation products and incubating under conditions suitable for forming at least some second ligation products,

combining at least one reverse transcriptase with the second ligation products to generate double-stranded second ligation products,

thereby reducing adapter-dimer formation.

10. The method of claim 9 , wherein the first ligase comprises T4 RNA ligase 2 or truncated T4 RNA ligase 2; the DNA-dependent DNA, polymerase comprises T4 DNA polymerase; and the second ligase comprises T4 RNA ligase 1 or Methanobacterium thermoautotrophicum RNA ligase.

11. The method of claim 9 wherein the 3′ adapter comprises 1-25 randomized bases at the 5′ end.

12. The method of claim 9 wherein the 5′ adapter comprises 1-25 randomized bases at the 3′ end.

13. method of claim 9 , further comprising amplifying ask least some of the double-stranded second ligation products to generate amplification products.

14. The method ref claim 13 , wherein the amplifying comprises Polymerase Chain Reaction (PCR).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2019
From: TOLOUE, MASOUD; MORRIS, ADAM R.; ALLEN, KEVIN D.
To: BIOO SCIENTIFIC CORPORATION
Reel/Frame 051378/0296 →
Continuity (2)
Provisional Application 62256662 · Nov 17, 2015
Related Publication 20170137875A1 · May 18, 2017
Cited By (1)
US 12,630,944